SHREE PACETRONIX

BSE: 527005 29 Jun 2025

Healthcare

₹ 71.29

Shree Pacetronix Ltd specializes in Medical Equipment & Supplies within the Healthcare sector.

SHREE PACETRONIX

BSE: 527005 29 Jun 2025

Healthcare

₹ 71.29

Shree Pacetronix Ltd specializes in Medical Equipment & Supplies within the Healthcare sector.

Book Value

38.3

Dividend Yield

0.0%

Debt to Equity

0.37

Stock P/E

35.0

Market Cap

26.2 Cr

SHREE PACETRONIX - Share Price & Details

Market Cap

₹26.2

High /Low

232.0 / 61.1

Stock P/E

35.0

Book Value

₹38.3

Dividend Yield

0.0

ROCE

8.96

ROE

₹5.59

Face Value

10.0

PEG Ratio

1.31

EVEBITDA

₹12.4

Debt

5.07

CMP / FCF

-48.6

Debt to equity

₹0.37

NP Ann

0.75

High price all time

392.0

Piotroski score

₹3.0

Graham Number

42.4

No. Eq. Shares

0.36

Net CF

₹0.14

Net profit

0.75

Price to book value

1.9

Interest Coverage

₹2.79

Low price all time

6.41

Industry PE

21.6

Reserves

₹10.2

Free Cash Flow

₹-0.73

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
LOOKS HEALTH SERVICES LIMITED	NA	NA	NA	NA	5.11	256.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
SHREE PACETRONIX LTD.	NA	NA	NA	NA	26.2	35.0
Adeshwar Meditex Limited	NA	NA	NA	NA	26	12.6
Global Longlife Hospital and R	NA	NA	NA	NA	25.5	127.0

Peer Comparison Chart

About SHREE PACETRONIX

Shree Pacetronix Ltd, with Security Code 527005, is a leading player in the Medical Equipment & Supplies industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Shree Pacetronix Reports Declining Sales and Profit Amid Market Challenges in March 2025

(01 Jun 2025)

Shree Pacetronix has reported its financial results for the quarter ending March 2025, revealing a challenging period marked by a decline in...

Pacemakers Market: Advancements in Cardiac Care Technology and Minimally Invasive Devices

(23 May 2025)

Pacemakers Market Overview (2025–2032). The Pacemakers Market is on the cusp of transformative growth, with projections indicating robust...

Quarterly Table

Standalone Consolidated

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	4.2	5.2	7.5	5.9	5.2	4.3	6.7	4.9	4.0	3.6
Expenses	3.5	4.1	4.5	4.5	4.1	3.4	4.4	4.1	3.7	3.5
Operating Profit	0.6	1.1	3.0	1.4	1.2	0.9	2.3	0.8	0.4	0.1
OPM %	15.52%	21.37%	39.89%	23.44%	22.09%	19.79%	34.42%	15.62%	9.27%	3.17%
Other Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2
Depreciation	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1
Profit before tax	0.4	0.9	2.8	1.2	0.9	0.6	2.0	0.5	0.1	-0.2
Tax %	-30.9%	-30.5%	-29.4%	-26.9%	-22.8%	-28.9%	-29.1%	-26.2%	-43.1%	-30.7%
Net Profit	0.3	0.6	2.0	0.9	0.7	0.4	1.4	0.4	0.0	-0.1
EPS in Rs	0.77	1.72	5.5	2.41	1.85	1.11	3.96	1.03	0.08	-0.32

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	4.2	5.2	7.5	5.9	5.2	4.3	6.7	4.9	4.0	3.6
Expenses	3.5	4.1	4.5	4.5	4.1	3.4	4.2	4.1	3.6	3.5
Operating Profit	0.7	1.1	3.0	1.4	1.2	0.8	2.4	0.8	0.4	0.1
OPM %	15.57%	21.31%	39.48%	23.39%	22.03%	19.72%	36.5%	16.15%	9.97%	3.97%
Other Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2
Depreciation	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2
Profit before tax	0.4	0.9	2.8	1.2	0.9	0.6	2.0	0.5	0.1	-0.2
Tax %	-30.8%	-30.9%	-29.4%	-26.9%	-22.9%	-29%	-29.1%	-26.1%	-37%	-31.9%
Net Profit	0.3	0.6	2.0	0.9	0.7	0.4	1.4	0.4	0.0	-0.1
EPS in Rs	0.79	1.71	5.44	2.4	1.85	1.1	3.98	1.03	0.09	-0.31

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	12%
5 Years:	25%
3 Years:	43%
TTM:	-16%

Compounded Profit Growth
10 Years:	31%
5 Years:	124%
3 Years:	165%
TTM:	-56%

Stock Price CAGR
10 Years:	0%
5 Years:	47%
3 Years:	61%
1 Year:	-63%

Compounded Sales Growth
10 Years:	11%
5 Years:	25%
3 Years:	43%
TTM:	-16%

Compounded Profit Growth
10 Years:	31%
5 Years:	117%
3 Years:	307%
TTM:	-56%

Stock Price CAGR
10 Years:	0%
5 Years:	47%
3 Years:	61%
1 Year:	-63%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

SHREE PACETRONIX

SHREE PACETRONIX

SHREE PACETRONIX - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About SHREE PACETRONIX

Latest News

Global Cardiac Resynchronization Therapy (CRT) Market Growth |

Pacemaker Market Booms with World's Smallest Rice-Sized

Sree Chitra transfers Parkinson’s care tech to industry partners

SCTIMST transfers six MedTech tech to industry

Shree Pacetronix Reports Declining Sales and Profit Amid Market Challenges in March 2025

Pacemakers Market: Advancements in Cardiac Care Technology and Minimally Invasive Devices

Shree Pacetronix Adjusts Evaluation Amid Mixed Performance and Growth Potential

Shree Pacetronix Faces Market Sentiment Shift Amid Flat Financial Performance

Shree Pacetronix Adjusts Evaluation Amid Mixed Financial Performance and Market Underperformance

Pacemakers Market Size to Hit USD 8.77 Billion by 2032,

Implantable Heart Pacemaker Market Valuation Expected To Reach $6.47 Billion By 2029 Growing At A Rate Of 5.7%

Key Trends Shaping the Future of Pacemakers Market:Pioneering Innovation In The Pacemaker Market With Leadl...

Shree Pacetronix Faces Significant Stock Volatility Amid Declining Financial Performance

Cardiac Resynchronization Therapy Market is Estimated to Grow

Shree Pacetronix Faces Significant Volatility Amidst Declining Financial Performance

Shree Pacetronix Faces Market Challenges Amid Significant Stock Volatility and Declining Performance

Shree Pacetronix Faces Continued Volatility Amidst Significant Stock Decline and Underperformance

Shree Pacetronix Faces Continued Stock Decline Amid Market Volatility and Operational Challenges

Shree Pacetronix Faces Significant Stock Volatility Amid Ongoing Operational Challenges

The Big Bad Smallcap Stocks Selloff. Here's How to Play this Opportunity...

Q3 Results Today: BHEL, Hyundai Motor India, Bajaj Auto, Suzlon Among 110+ Companies To Declare Earnings Today

Cardiac Resynchronization Therapy Market Opportunities

Pacemakers Market Analysis, Industry Size, Share, Key Players And Forecast To 2033

Which Companies Manufacture Medical Equipment in India?

Pacemakers and Implantable Cardioverter Defibrillators

Pacemakers Market to Witness Massive Growth with Medtronic, LivaNova, Medico

Key Pacemakers Market Trend 2024-2033: Miniaturized Pacemakers

Primary Cells Market Size to Reach USD 13.11 Billion by 2031 | SkyQuest Technology

Global Cardiovascular Implants Market Report Details 2024 - Business Opportunities, Industry Growth, Region...

Shree Pacetronix Hits 52-Week Low Amidst Decline in Medical Equipment Industry

Shree Pacetronix Hits 52-Week Low, Underperforms Market in Medical Equipment Industry

Shree Pacetronix Hits 52-Week Low with Strong Sell Rating from MarketsMOJO

Q2 Results Today: HDFC Bank, RBL Bank, Kotak Mahindra Bank, 19 others to declare Q2 results 2024 on Saturday — Oct 19

Sensex rises! But these stocks are down 5% or more on BSE

Shree Pacetronix consolidated net profit declines 95.52% in the September 2024 quarter

Shree Pacetronix Remains Resilient in Challenging Market, Focusing on Improving Financial Performance

Shree Pacetronix Hits 52-Week Low, Receives Strong Sell Rating from MarketsMOJO

PC Jeweller reports consolidated net profit of Rs 178.88 crore in the September 2024 quarter

Q2 Results Today: HDFC Bank, RBL Bank, Kotak Mahindra Bank, 19 others to declare Q2 results 2024 on Saturday — Oct 19 | Company Business News

HDFC Bank, PC Jeweller, RBL Bank, Tech Mahindra Among 20+ Companies To Declare Q2 Results Today

Pacemakers Market Size, Share, Growth Insights and Report 2024-2031 | Livanova, Osypka Medical, Shree Pacetronix

Q2 Results: HCL Tech, Bajaj Auto, RIL, Axis Bank among 144 companies to declare July-Sept quarter results this week | Company Business News

Q2 Results: HCL Tech, Bajaj Auto, RIL, Axis Bank among 144 companies to declare July-Sept quarter results this week

Global Implantable Heart Pacemaker Market Overview And Statistics For 2024-2033

Implantable Cardioverter Defibrillator (ICD) Market Strategies and Forecast Till, (2024-2034)

Heart Blocks Treatment Devices Market Size, Opportunities And Scope By 2033

Cardiac Pacemaker Devices Market Size, Share, Trends, Competitive Landscape, Regional Analysis Forecasts By...

United States Implantable Cardioverter Defibrillator (ICD) Market By Application – news

United States Implantable Cardioverter Defibrillator (ICD) Market By Application

Implantable Heart Pacemaker Market Overview In The New Analysis By Leading Research Firm

Heartbeat of Innovation: Pacemakers Global Market Evolution – 2024 Report

Cardiac Rhythm Management (CRM) Devices And Equipment Market Research In The New Analysis By Leading Resear...

Bradycardia Treatment Devices Market Report: In-Depth Analysis of Technological Innovations, Growth Forecas...

North America Implantable Cardioverter Defibrillator (ICD) Market By Applications

Implantable Cardiac Pacemaker Treatment Market Booming

Cardiovascular Implants Market Innovations Investigated by Size, Demand, Share, Forecast, Trends To 2033

Cardiac Resynchronization Therapy Market Booming Worldwide

Congestive Heart Failure (CHF) Treatment Devices Market

Shree Pacetronix consolidated net profit declines 56.98% in the June 2024 quarter

Shree Pacetronix's Financial Performance Declines, Receives 'Strong Sell' Rating from MarketsMOJO

Q1 results today: Aurobindo Pharma, APL Apollo Tubes, Finolex Cables, others to post earnings on August 10; check list

Implantable Cardiac Pacemaker Market Generated

Cardiac Resynchronization Therapy Industry to Witness Massive Growth (2024-2034) |Medtronic, PLC, Abbott Laboratories, Lepu M – அக்னி செய்திகள்

Global Pacemakers Market is Expected to Grow at a CAGR of 4.2% over the Forecast Period (2024 – 2034): A Report by TNR, The Niche Research

Cardiac Pacemaker Companies | Forecast by 2034

Global Cardiac Pacing Market 2024 Analysis by Top Key Players |MEDICO S.p.A., LivaNova PLC, Shree Pacetronix Ltd.

Cardiac Prosthetic Devices Market size is set to grow by USD 5.07 billion from 2024-2028, Rising prevalence of cardiac disorders to boost the market growth, Technavio

Congestive Heart Failure Treatment Device Market Size To Reach $28.22 Billion By 2032

Heart Blocks Treatment Devices Global Market 2024 To Reach $4.13 Billion By 2028 At Rate Of 5.7%

Dual-chamber Pacemaker Market Growing Massively by MicroPort Scientific Corporation, Boston Scientific Corporation, Osypka Medical GmbH, Zoll Medical Corporation – TIMC

Pacemakers And Implantable Cardioverter Defibrillators (icds) Market See Huge Growth for New Normal | Medtronic Inc., Boston Scientific, ZOLL Medical Corp., Asahi Kasei Corp. – TIMC